Search / Trial NCT06226831

Onset of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients

Launched by UNIVERSITY HOSPITAL OSTRAVA · Jan 17, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Multiple Sclerosis Lower Urinary Tract Symptoms Urinary Urgency Cerebellar And/Or Pyramidal Symptoms

ClinConnect Summary

This clinical trial is investigating when patients with multiple sclerosis (MS) first start to experience problems with their bladder and urinary function, known as lower urinary tract symptoms. Researchers are gathering information by asking patients about their first symptoms and the date they began, and they are also looking at medical records to confirm this information. The goal is to better understand how these symptoms develop in people with MS.

To participate in this study, you need to be an adult who has been diagnosed with multiple sclerosis and willing to provide informed consent, which means you agree to take part after being fully informed about the study. There are no specific exclusions, so if you meet the diagnosis criteria, you may be eligible. If you choose to take part, you can expect to share your experiences during a structured interview, helping researchers gather important data that could improve the understanding and treatment of urinary issues in MS patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosis of multiple sclerosis
  • adult patients
  • signed informed consent
  • Exclusion Criteria:
  • - none

Trial Officials

Jan Krhut, prof.,MD, PhD

Principal Investigator

University Hospital Ostrava

About University Hospital Ostrava

University Hospital Ostrava is a leading medical research institution located in Ostrava, Czech Republic, dedicated to advancing healthcare through innovative clinical trials and research initiatives. As a prominent sponsor of clinical studies, the hospital combines cutting-edge medical technology with a commitment to patient-centered care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a focus on ethical standards and regulatory compliance, University Hospital Ostrava aims to contribute to the development of new therapies and improve treatment outcomes across various medical fields. Its robust research infrastructure and dedication to scientific excellence position it as a key player in the advancement of medical knowledge and patient care.

Locations

Ostrava, Moravian Silesian Region, Czechia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0